FDA Adverse Event Injury Summary report: N

TRULIANT PS POR FEM PS POR LEFT SZ 3.5

MDR report key: 15419116 · Received September 14, 2022

Report

Report Number
1038671-2022-01112
Event Type
Injury
Date Received
September 14, 2022
Date of Event
August 24, 2022
Report Date
February 17, 2026
Manufacturer
EXACTECH, INC.
Product Code
MBH
UDI-DI
10885862314796
PMA / PMN Number
K181794
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

PENDING INVESTIGATION. CONCOMITANT MEDICAL PRODUCTS: 6739119, 02-020-12-0235 - TRULIANT PS POR FEM PS POR LEFT SZ 3.5; 6030524, 02-022-55-3525 - TRULIANT POR TIB TRAY SIZE 3.5F/25T; ;6982635, 200-07-32 - ADVANCED PATELLA 32MM 3 PEG IMPLANT.

Additional Manufacturer Narrative · 0

H3: THE REVISION REPORTED WAS LIKELY THE RESULT OF AN INSUFFICIENT BOND BETWEEN THE FEMORAL COMPONENT AND THE BONE, WHICH LED TO ASEPTIC (NON-INFECTED) FEMORAL LOOSENING, OSTEOLYSIS, AND PAIN. HOWEVER THIS CANNOT BE CONFIRMED AS THE DEVICES WERE NOT RETURNED FOR EVALUATION AND PRE-REVISION RADIOGRAPHS WERE UNABLE TO BE OBTAINED. H7: Z-0023-2022.

Description of Event or Problem · 0

AS REPORTED, THE PATIENT HAD AN INITIAL LEFT TKA ON (B)(6) 2021. THE PATIENT COMPLAINED OF SEVER PAIN, A POSSIBLE LOOSE FEMUR, AND WAS REVISED TO A COMPETITOR'S PRODUCT. THE PATIENT WAS LAST KNOWN TO BE IN STABLE CONDITION FOLLOWING THE EVENT. NO OTHER PATIENT INFORMATION/MEDICAL HISTORY REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2667909 TRULIANT PS POR FEM PS POR LEFT SZ 3.5 PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED MBH EXACTECH, INC. TRULIANT TIB IMP PS INSERT SZ 3.5 9MM 10885862314796
986911 TRULIANT PS POR FEM PS POR LEFT SZ 3.5 PROSTHESIS, KNEE, PATELLO/FEMOROTIBIAL, SEMI-CONSTRAINED, UNCEMENTED MBH EXACTECH, INC. TRULIANT TIB IMP PS INSERT SZ 3.5 9MM 10885862314796

Patients

Seq Age Sex Outcome Treatment
1 61 YR Female Required Intervention SEE H10